User profiles for Manuel Rubio-Rivas
 | Manuel Rubio-RivasScleroderma and Sarcoidosis Section. Autoimmune Diseases Unit. Department of Internal … Verified email at bellvitgehospital.cat Cited by 3461 |
Mortality and survival in systemic sclerosis: systematic review and meta-analysis
M Rubio-Rivas, C Royo, CP Simeón, X Corbella… - Seminars in arthritis and …, 2014 - Elsevier
Objective To determine the mortality, survival, and causes of death in patients with systemic
sclerosis (SSc) through a meta-analysis of the observational studies published up to 2013. …
sclerosis (SSc) through a meta-analysis of the observational studies published up to 2013. …
[HTML][HTML] Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry …
…, J Tejada Montes, M Rubio-Rivas… - PloS one, 2021 - journals.plos.org
Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-infections
are rare. This can lead to increased complications, including antibacterial …
are rare. This can lead to increased complications, including antibacterial …
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
…, J Olas, S Paul, C Rotondo, M Rubio-Rivas… - The Lancet …, 2020 - thelancet.com
Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …
[HTML][HTML] Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide …
…, LJ Huerta, JA Muñoz, M Rubio-Rivas… - BMC medicine, 2020 - Springer
Background Limited evidence exists on the role of glucose-lowering drugs in patients with
COVID-19. Our main objective was to examine the association between in-hospital death and …
COVID-19. Our main objective was to examine the association between in-hospital death and …
Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación auricular: datos del registro SEMI-COVID-19
Introducción La fibrilación auricular y las comorbilidades asociadas a ella suponen un factor
de riesgo de mortalidad, morbilidad y de desarrollo de complicaciones en los pacientes …
de riesgo de mortalidad, morbilidad y de desarrollo de complicaciones en los pacientes …
[HTML][HTML] Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: an analysis of 12,066 hospitalized patients from the Spanish registry SEMI …
M Rubio-Rivas, X Corbella, JM Mora-Luján… - Journal of clinical …, 2020 - mdpi.com
(1) Background: Different clinical presentations in COVID-19 are described to date, from
mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 …
mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 …
[HTML][HTML] Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
…, E Muñez Rubio, M Rubio-Rivas… - BMC infectious …, 2021 - Springer
Background Since December 2019, the COVID-19 pandemic has changed the concept of
medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital …
medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital …
Occupational and environmental scleroderma. Systematic review and meta-analysis
M Rubio-Rivas, R Moreno, X Corbella - Clinical rheumatology, 2017 - Springer
The etiology of systemic sclerosis (SSc) remains unknown; however, several occupational
and environmental factors have been implicated. Our objective was to perform a meta-…
and environmental factors have been implicated. Our objective was to perform a meta-…
[HTML][HTML] Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a …
J Mañá, M Rubio-Rivas, N Villalba, J Marcoval… - Medicine, 2017 - journals.lww.com
Cohort studies of large series of patients with sarcoidosis over a long period of time are scarce.
The aim of this study is to report a 40-year clinical experience of a large series of patients …
The aim of this study is to report a 40-year clinical experience of a large series of patients …
Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain
…, MC Sáez, S Campos Escudero, M Rubio-Rivas… - …, 2021 - Am Heart Assoc
Older age and cardiovascular comorbidities are well-known risk factors for all-cause mortality
in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 …
in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 …